| 354d12f0-1fdb-44b9-ab55-07e8a50d3de2 | 1513 | QUIMIOTERAPIA DO ADENOCARCINOMA DE ESTÔMAGO AVANÇADO | 228 | 1571 | 0304020044 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| a554faeb-73d9-4ece-9206-d8a2b1c8f91d | 1514 | QUIMIOTERAPIA DO ADENOCARCINOMA DE PÂNCREAS AVANÇADO | 228 | 1571 | 0304020052 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| ac829817-0bfd-48d8-8f0a-a5c5819c78f5 | 1515 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 2ª LINHA | 228 | 1571 | 0304020060 | 202402 | 1 | 0 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.275000+00:00 | 2021-05-25T19:39:57.275000+00:00 |
| c7717028-51ab-4d15-bf5b-a51b42e5d768 | 1516 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 1ª LINHA | 228 | 1571 | 0304020079 | 202402 | 1 | 0 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.275000+00:00 | 2021-05-25T19:39:57.275000+00:00 |
| 3fe46a4b-613d-4960-adb8-30233174ed88 | 1517 | QUIMIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA RESISTENTE A HORMONIOTERAPIA | 228 | 1571 | 0304020087 | 202402 | 1 | 0 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| de910938-7f4d-45cf-85c8-4c2d82c39e49 | 1518 | QUIMIOTERAPIA DO CARCINOMA DE RETO AVANÇADO -1ª LINHA | 228 | 1571 | 0304020095 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| d372c9d6-83b7-471d-a3ed-92dab67423e1 | 1519 | QUIMIOTERAPIA DO CARCINOMA DE RETO AVANÇADO - 2ª LINHA | 228 | 1571 | 0304020109 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 59bc4bbb-d51f-4c14-9cc7-7df9108c84eb | 1520 | QUIMIOTERAPIA DO APUDOMA/TUMOR NEUROENDÓCRINO AVANÇADO | 228 | 1571 | 0304020117 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 19dd1ad2-f75e-4f06-be0c-4a313eae95c4 | 1521 | QUIMIOTERAPIA DO CARCINOMA DE ADRENAL AVANÇADO | 228 | 1571 | 0304020125 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 4a1263e9-f115-4e47-a597-04e6f6fd1f78 | 1522 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO -1ª LINHA | 228 | 1571 | 0304020133 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| e8102b7f-58ad-44b0-bcbb-d36866b14ef9 | 1523 | QUIMIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 228 | 1571 | 0304020141 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 784f1149-6da8-4421-9268-fe2a1057418b | 1524 | QUIMIOTERAPIA DO CARCINOMA DE NASOFARINGE AVANÇADO | 228 | 1571 | 0304020150 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 3ea088c8-ed0d-4377-9271-31157e3478a1 | 1525 | QUIMIOTERAPIA DO CARCINOMA DE RIM AVANÇADO | 228 | 1571 | 0304020168 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 94d2ff66-093d-46ae-87be-e3c8056c89cc | 1526 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE / ADENOCARCINOMA DE ESÔFAGO AVANÇADO | 228 | 1571 | 0304020176 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 331e8af4-bf4c-4510-ab19-a851a06d8c8c | 1527 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE / ADENOCARCINOMA DO COLO OU DO CORPO UTERINO AVANÇADO | 228 | 1571 | 0304020184 | 202402 | 0 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| ff4ebff4-d17e-49d1-85d6-387b3d3564de | 1530 | QUIMIOTERAPIA DO CARCINOMA PULMONAR DE CÉLULAS NÃO PEQUENAS AVANÇADO | 228 | 1571 | 0304020214 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 79b8db99-dea8-4208-a0e6-213aeeed5c13 | 1531 | QUIMIOTERAPIA DO CARCINOMA PULMONAR INDIFERENCIADO DE CÉLULAS PEQUENAS AVANÇADO | 228 | 1571 | 0304020222 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 1e80459e-7601-4732-a220-39624e39ed32 | 1536 | QUIMIOTERAPIA DE NEOPLASIA MALIGNA EPITELIAL DE OVÁRIO OU DE TUBA UTERINA AVANÇADA -1ª LINHA. | 228 | 1571 | 0304020273 | 202402 | 0 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 159ca144-5116-4615-9a90-0fd1853c9030 | 1538 | QUIMIOTERAPIA DE SARCOMA DE PARTES MOLES AVANÇADO | 228 | 1571 | 0304020290 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 3000111c-8df0-4aa1-bdfc-707c85c4e9ae | 1540 | QUIMIOTERAPIA DO TUMOR DO ESTROMA GASTROINTESTINAL AVANÇADO | 228 | 1571 | 0304020311 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| b8bb8995-344f-4241-a783-ff7d4941579d | 1542 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 228 | 1571 | 0304020338 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.275000+00:00 | 2021-05-25T19:39:57.275000+00:00 |
| 69c3aad4-1cdd-40f7-bc80-9ee05a04bda0 | 1543 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO- 1ª LINHA | 228 | 1571 | 0304020346 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.275000+00:00 | 2021-05-25T19:39:57.275000+00:00 |
| 90dc1b92-13d7-4887-a758-9b99f1c0c845 | 1544 | QUIMIOTERAPIA DO CARCINOMA DE TIREOIDE AVANÇADO | 228 | 1571 | 0304020362 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| e71fb716-be52-443f-ad3f-7806b51a41ee | 1545 | QUIMIOTERAPIA DO CARCINOMA DE PÊNIS AVANÇADO | 228 | 1571 | 0304020370 | 202402 | 1 | 0 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 39df6425-de65-4ba8-828a-3c4e00b55b23 | 1548 | QUIMIOTERAPIA DE CARCINOMA UROTELIAL AVANÇADO | 228 | 1571 | 0304020400 | 202402 | 1 | 1 | 3 | 3 | 27 | 75 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 08687f49-d6f1-4002-bf1f-e907fd318e3e | 1549 | QUIMIOTERAPIA DE DOENÇA LINFOPROLIFERATIVA RARA -1ª LINHA. | 228 | 1571 | 0304030015 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 9c4b04c9-2088-4747-9cf0-565b7cf20cf4 | 1550 | QUIMIOTERAPIA DE DOENÇA LINFOPROLIFERATIVA RARA - 2ª LINHA | 228 | 1571 | 0304030023 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| f2fbfadb-1539-454b-bf1c-4f464da9f131 | 1553 | QUIMIOTERAPIA DE LEUCEMIA LINFOCITICA CRONICA - 1ª LINHA. | 228 | 1571 | 0304030058 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 56197b4a-f037-4005-8669-7ca6f1cfc6a0 | 1554 | QUIMIOTERAPIA DE LEUCEMIA LINFOCITICA CRONICA - 2ª LINHA. | 228 | 1571 | 0304030066 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 3a25d4ad-e275-4d50-9b17-53582fab7605 | 1555 | QUIMIOTERAPIA DE LEUCEMIA MIELOIDE CRONICA QUALQUER FASE - CONTROLE SANGÜINEO | 228 | 1571 | 0304030074 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| fe3fab8b-ceed-4103-ae12-d9eb21288def | 1556 | QUIMIOTERAPIA DA LEUCEMIA MIELÓIDE CRÔNICA EM FASE BLÁSTICA - MARCADOR POSITIVO - 2ª LINHA. | 228 | 1571 | 0304030082 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 6e200e34-57eb-40b2-b25b-26e516141754 | 1557 | QUIMIOTERAPIA DA LEUCEMIA MIELÓIDE CRÔNICA EM FASE BLASTICA - MARCADOR POSITIVO - SEM FASE CRÔNICA OU DE TRANSFORMAÇÃO ANTERIOR (1ª LINHA). | 228 | 1571 | 0304030090 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 12a80259-dc1e-4035-8bfe-7001590beac8 | 1558 | QUIMIOTERAPIA DE LEUCEMIA MIELÓIDE CRÔNICA EM FASE BLÁSTICA - MARCADOR POSITIVO-3ª LINHA | 228 | 1571 | 0304030104 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 5aa17bf3-d6c6-49cb-bd36-798fb801da97 | 1559 | QUIMIOTERAPIA DA LEUCEMIA MIELÓIDE CRÔNICA EM FASE CRÔNICA - MARCADOR POSITIVO - 1ª LINHA. | 228 | 1571 | 0304030112 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 9b9c3ff0-f453-4dda-a1e0-3a0fc75984a0 | 1560 | QUIMIOTERAPIA DE LEUCEMIA MIELÓIDE CRÔNICA EM FASE CRÔNICA - MARCADOR POSITIVO - 3ª LINHA | 228 | 1571 | 0304030120 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 4b89e32a-069d-4aa3-ad45-67d999a9d72b | 1561 | QUMIOTERAPIA DE LEUCEMIA MIELÓIDE CRÔNICA EM FASE DE TRANSFORMAÇÃO - MARCADOR POSITIVO - 3ª LINHA | 228 | 1571 | 0304030139 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 585f701d-2482-4971-84eb-910cda37c2dd | 1562 | QUIMIOTERAPIA DA LEUCEMIA MIELÓIDE CRÔNICA EM FASE DE TRANSFORMAÇÃO - MARCADOR POSITIVO - 2ªLINHA | 228 | 1571 | 0304030147 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 937e1046-1641-40d4-abe2-3265019ecff6 | 1563 | QUIMIOTERAPIA DE LEUCEMIA MIELÓIDE CRÔNICA EM FASE DE TRANSFORMAÇÃO - MARCADOR POSITIVO - SEM FASE CRONICA ANTERIOR (1ª LINHA) | 228 | 1571 | 0304030155 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| aa300209-b59a-4cc6-904a-d9e7d1b8ca40 | 1564 | QUIMIOTERAPIA DE LINFOMA NÃO HODGKIN DE BAIXO GRAU DE MALIGNIDADE (1ª LINHA) | 228 | 1571 | 0304030163 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 0a2796d4-f4be-4600-9173-a611f6353b7b | 1565 | QUIMIOTERAPIA DE LINFOMA NÃO HODGKIN DE BAIXO GRAU DE MALIGNIDADE - 2ªLINHA | 228 | 1571 | 0304030171 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 2dfad34a-77d2-4770-ade2-552dc76fe17e | 1566 | QUIMIOTERAPIA DE NEOPLASIA DE CÉLULAS PLASMÁTICAS - 1ª LINHA. | 228 | 1571 | 0304030180 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 5a6aef10-a3c4-439b-9e44-6f21f6a3c82a | 1567 | QUIMIOTERAPIA DE NEOPLASIA DE CÉLULAS PLASMÁTICAS - 2ª LINHA. | 228 | 1571 | 0304030198 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| a051e977-0f74-4f03-9b99-67a0e6f58e70 | 1568 | QUIMIOTERAPIA DA TRICOLEUCEMIA - 2ª LINHA | 228 | 1571 | 0304030201 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 060dd973-0f9a-49fc-a996-f4bdf16a52c9 | 1569 | QUIMIOTERAPIA DE TRICOLEUCEMIA - 1ªLINHA. | 228 | 1571 | 0304030210 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 0ebea7a1-699a-48fb-9add-5eea0e1c4259 | 1570 | QUIMIOTERAPIA DE LEUCEMIA MIELÓIDE CRÔNICA EM FASE CRÔNICA - MARCADOR POSITIVO - 2ª LINHA | 228 | 1571 | 0304030228 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| 3be098b1-37fe-4362-b666-ce191122f724 | 4605 | QUIMIOTERAPIA DE LINFOMA FOLICULAR- 1ª LINHA | 228 | 1571 | 0304030236 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| ea7b3644-9be0-4bc4-89a5-b7e732435421 | 4606 | QUIMIOTERAPIA DE LINFOMA FOLICULAR - 2ª LINHA | 228 | 1571 | 0304030244 | 202402 | 1 | 1 | 3 | 3 | 27 | 120 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| ce87fb86-956a-4748-89ff-bb68ecc70947 | 1572 | QUIMIOTERAPIA DO CARCINOMA DE MAMA (PRÉVIA) | 228 | 1571 | 0304040029 | 202402 | 1 | 1 | 3 | 3 | 27 | 155 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| e436aa46-924c-42bf-bbea-6d31f8b593ab | 1573 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE / ADENOCARCINOMA DO COLO UTERINO | 228 | 1571 | 0304040045 | 202402 | 0 | 1 | 3 | 3 | 27 | 155 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |
| dc32a4f4-858b-49f0-88f0-9af7122a7f78 | 1574 | QUIMIOTERAPIA DO CARCINOMA EPIDERMÓIDE DE RETO/ CANAL ANAL/ MARGEM ANAL | 228 | 1571 | 0304040053 | 202402 | 1 | 1 | 3 | 3 | 27 | 155 | 1 | <span class="null">NULL</span> | 1 | CLINICO | <span class="null">NULL</span> | <span class="null">NULL</span> | 0 | <span class="null">NULL</span> | 1 | 2021-05-25T19:39:57.281000+00:00 | 2021-05-25T19:39:57.281000+00:00 |